Publications
- Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Faculty of Mathematics and Physics
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Cytochrome b(5) Increases Cytochrome P450 3A4-Mediated Activation of Anticancer Drug Ellipticine to 13-Hydroxyellipticine Whose Covalent Binding to DNA Is Elevated by Sulfotransferases and N,O-Acetyltransferases2012 | Faculty of Science, Second Faculty of Medicine
- Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the P-32-postlabeling technique2012 | Faculty of Science, Second Faculty of Medicine
- Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma2011 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- DNA and histone deacetylases as targets for neuroblastoma treatment2010 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport
- Premature aging in childhood cancer survivors (Review)2023 | Second Faculty of Medicine
- KDM5B expression in cisplatin resistant neuroblastoma cell lines2022 | Second Faculty of Medicine
- Semen analysis and treatment risk factors in long-term survivors of childhood cancer2021 | Second Faculty of Medicine, Central Library of Charles University
Loading network view...